Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule - Results of a post-marketing surveillance

Vaccine

Volumn 15, Issue 4, 1997, Pages 349-352

  Clemens, Ralf ^a   Sänger, Roland ^a   Kruppenbacher, Johannes ^b   Höbel, Wilfried ^a   Stanbury, William ^a   Bock, Hans L ^a   Jilg, Wolfgang ^c  

^a SmithKline Beecham Pharma GmbH   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

hepatitis B vaccine; non responders; slow responders

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; BODY MASS INDEX; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; SEX FACTORS; VACCINES, SYNTHETIC;

EID: 0342872027     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00205-8     Document Type: Article

References (24)

1. World Health Organization. Progress in the control of viral hepatitis: Memorandum from a WHO meeting. Bull. WHO. 1988, 66, 443-445
2. André, F.E. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990, 8 suppl. 1, S74-S78
3. West, D.J. Clinical experience with hepatitis B vaccines. Am. J. Infect. Control. 1989, 17, 172-180
4. Jilg, W., Schmidt, M. and Deinhardt, F. Vaccinations against hepatitis B: comparison of three different vaccination schedules. J. Infect. Dis. 1989, 160, 766-769
5. Wainwright, R.B., McMahon, B.J. and Bulkow, L.R. et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. J. Am. Med. Assoc. 1989, 261, 2362-2366
6. Coursaget, P., Yvonnet, B. and Chotard, J. et al. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986, ii, 1143-1145
7. Whittle, H.C., Inskip, H., Hall, A.J., Mendy, M., Downes, R. and Hoare, S. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 1991, 337, 747-750
8. Jilg, W. and Deinhardt, F. Hepatitis B - Impfung heute. Münch. Med. Wochenschr. 1988, 130, 361-362
9. Jilg, W., Schmidt, M. and Deinhardt, F. Impfversagen nach Hepatitis-B-Impfung. Dtsch. Med. Wochenschr. 1990, 115, 1545-1548
10. Filion, L.G., Saginur, R. and Szczerbak, N. Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination. Clin. Exp. Immunol. 1988, 71, 405-409
11. Hess, G., Hingst, V., Cseke, J., Bock, H.L. and Clemens, R. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur. J. Clin. Microbiol. Infect. Dis. 1992, 11, 334-340
12. Redeker, A.G., Mosley, J.W., Gocke, D.J., McKee, A.P. and Pollack, W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N. Engl. J. Med. 1975, 293, 1055-1059
13. Seeff, L.B., Wright, E.C., Zimmermann, H.J. et al. Type B hepatitis after needlestick exposure: prevention with hepatitis B immunoglobulin. Final report of the Veterans Administrative Cooperative Study. Ann. Intern. Med. 1978, 88, 285-293
14. Hadler, S.C., Francis, D.P. and Maynard, J.E. et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N. Engl. J. Med. 1986, 315, 209-214
15. Craven, D.E., Awdeh, Z.L. and Kunches, L.M. et al. Nonresponsiveness to hepatitis B vaccine in healthcare workers: results of revaccination and genetic typings. Ann. Intern. Med. 1986, 105, 356-360
16. Louagie, H., Delanghe, J., Desombere, I., De Buyzere, M., Hauser, P. and Leroux-Roels, G. Haptoglobin polymorphism and the immune response after hepatitis B vaccination. Vaccine 1993, 11, 1188-1190
17. Lee, S-D. and Tong, M.J. Correlation between peripheral lymphocyte subsets and antibody to hepatitis B surface antigen response in hepatitis B vaccine recipients. Scand. J. Infect. Dis. 1985, 17, 333-335
18. Jabaaij, L., Grosheide, P.M., Heijtink, R.A., Duivenvoorden, H.J., Ballieux, R.E. and Vingerhoets, A.J.J.M. Influence of perceived psychological stress and distress on antibody response to low dose rDNA hepatitis B vaccine. J. Psychosom. Res. 1993, 37, 361-369
19. Husband, A.J. Role of central nervous system and behaviour in the immune response. Vaccine 1993, 11, 805-816
20. Chriske, H.W., Bock, H.L. and Clemens, R. Immunantwort auf nachimpfungen mit einer rekombinanten Hepatitis-B-Vakzine bei low-und non-respondern. Arbeitsmed. Sozialmed. Präventivmed. 1990, 25, 421-422
21. Gesemann, M. and Scheiermann, N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995, 13, 443-447
22. Horowitz, M.M., Ershler, W.B., McKinney, W.P. and Battiola, R.J. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Ann. Intern. Med. 1988, 108, 185-189
23. Hadler, S.C. Are booster doses of hepatitis B vaccine necessary?. Ann. Intern. Med. 1988, 108, 457-458
24. Barnas, G.P. and Hanacik, L.J. Hepatitis B vaccine: persistence of antibody following immunization. Infect. Control. Hosp. Epidemiol. 1988, 9, 147-150